Increased Expression of Capn4 is Associated with the Malignancy of Human Glioma.

CONCLUSION: The overexpression of Capn4 is a novel negative prognostic marker, and Capn4 may be used as a new target in therapeutic strategies for human glioma. PMID: 24628706 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24628706?dopt=Abstract

Source: CNS Neuroscience and Therapeutics - March 15, 2014 Category: Neuroscience Authors: Cai JJ, Qi ZX, Hua W, Zhu JJ, Zhang X, Yao Y, Mao Y Tags: CNS Neurosci Ther Source Type: research